Publications
Book/Book Chapters
Book: Micro- and Nanotechnologies Based Sterile Product Development. Editors: Dr. Neelsh Kumar Mehra and Dr. Arvind Gulbake, 2021, Publisher: CRC Press, Taylor & Francis Group, LLC., ISBN 9780367488451
“Bentley’s: Text Book of Pharmaceutics” An Adoptation: edited by Jain SK & Soni V. original editor E. A. Rawlin, Chapter title “New Drug Delivery Systems” Gulbake A, Soni V & Jain SK. 2011, Published by Elsevier India Pvt. Ldt. New Delhi.
“Chitosan: Manufacture, properties, and usage” edited by Davis SP. Chapter title “Chitosan: A Potential Bio-Polymer for Drug Delivery” Jain SK, Khare P, Gulbake A & Shilpi S. 2010, Published by NOVA Science Publisher. ISBN: 978-1-61761-051-6.
“Oral Modified Release Drug Delivery Systems” Editors: Piush Khare, Mohini Chaurasia, Sarvesh K. Paliwal. Chapter title “Colon Specific Drug Delivery Systems” Gulbake A, Kumar P, Khare P, Jain N.K. 2016, Pharmamed Press, Hyderabad. ISBN No. 9789352301010.
“Functional Hydrogels in drug delivery: Key features and future prospective” Chapter title “Prodrugs and Bioconjugate Hydrogels: A Valuable Strategy for the Prolonged-Delivery of Drugs” Jain A, Sahu A, Jain A, Gulbake A. 2017, Science Publisher in cooperation with CRC press. ISBN-97814 9874 9015.
Peer-Reviewed National/International Publications
(Google Scholar Citations>1195 & h-index:19; Scopus Citations>856 & h-index:19)
(Google Scholar Citations>1195 & h-index:19; Scopus Citations>856 & h-index:19)
1. Gulbake A, Jain A, Khare P & Jain SK. (2010). Solid lipid nanoparticles bearing oxybenzone: In vitro in vivo evaluation. J Microencap. 27(3):226-33. (IF= 1.793)
2. Mishra P, Gulbake A, Jain A, Khare P, Soni V, Vyas SP & Jain SK. (2009). Steroid receptors as molecular targets for cancer diagnosis and therapy. Cri Rev Ther Drug Carrier Sys. 26(3):207-73. (IF= 3.32)
3. Mishra P, Gulbake A, Jain A, Vyas SP & Jain SK. (2009). Targeted delivery of an anti-cancer agent via steroid coupled liposomes. Drug Del. 16(8):437-47. (IF= 6.402)
4. Khare P, Jain A, Gulbake A, Soni V, Jain NK & Jain SK. (2009). Bioconjugates: Harnessing potential for effective therapeutics. Cri Rev Ther Drug Carrier Sys. 26(2):119-55. (IF= 3.32)
5. Bagari R, Bansal D, Gulbake A, Jain A, Soni V & Jain SK. (2011). Chondroitin sulfate functionalized liposomes for solid tumor targeting. J Drug Targ. 19(4):251-57. (IF= 3.408)
6. Jain S, Jain S, Khare P, Gulbake A, Bansal D & Jain SK. (2010). Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent. Drug Del. 17, (6): 443-51. (IF= 6.402)
7. Soni V, Jain A, Khare P, Gulbake A & Jain SK. (2010) Potential approaches for drug delivery to the brain: Past, present, and future. Cri Rev Ther Drug Carrier Sys. 27(3):187-236. (IF= 3.32)
8. Jain SK, Jain A, Gulbake A, Shilpi S & Khare P. (2010). Steroid Coupled liposomes for targeted delivery to tumor. Ther Del. Future Science Group. 1(2): 345-357. (Scopus)
9. Rathore A, Jain A, Gulbake A, Shilpi S, Khare P, Jain A & Jain SK. (2010). Mannosylated liposomes bearing amphotericin B for effective management of visceral leishmaniasis. J Lipo Res. 21(4):333-40. (IF= 2.576)
10. Mahalwar A, Gulbake A, Jain A, Shilpi S, Sharma B, Joshi B & Jain SK. (2012). Evaluation of Effect of Ligand on Cellular Internalization: a Comparative Study of Nanoparticles and Multifunctional Nanoparticles on MDA-MB-231 Cells. Curr Nanosci. 8(3): 432-40. (IF= 1.306)
11. Jain A, Gulbake A, Jain A, Shilpi S, Hurkat P, Jain A & Jain SK. (2012). Development of surface-functionalised nanoparticles for FGF2 receptor-based solid tumor targeting. J Microencap. 29(1): 95-102. (IF= 1.793)
12. Jain A, Jain A, Gulbake A, Hurkat P & Jain SK. (2011). Solid tumors: A review. Int J Phar Pharm Sci. 3(5): 45-51.
13. Kumar P, Gulbake A & Jain SK. (2012). Liposomes a vesicular nanocarrier: Potential advancements in cancer chemotherapy. Cri Rev Ther Drug Carrier Sys. 29(5) 355-419. (IF= 3.32)
14. Gulbake A & Jain SK. (2012). Chitosan: A potential polymer for colon-specific drug delivery system. Exp Opin Drug Del. 9(6): 713-729. (IF= 5.6)
15. Hurkat P, Jain A, Jain A, Shilpi S, Gulbake A & Jain SK. (2012). Concanavalin A conjugated biodegradable nanoparticles for oral insulin delivery. J Nano Res. 14(11): 1-14. (IF= 2.18)
16. Gulbake A, Jain A & Jain SK. (2012). Development of nanostructured lipid carrier as potential sun protectant. Nanosci & Nanotech-Asia. 2:210-216.
17. Jain A, Gulbake A, Shilpi S, Jain A, Hurkat P & Jain SK. (2013). A new horizon in modifications of chitosan: Syntheses and applications. Cri Rev Ther Drug Carrier Sys. 30(2): 91–181. (IF= 3.32)
18. Nema T, Jain A, Jain A, Shilpi S, Gulbake A, Hurkat P & Jain SK. (2013). Insulin delivery through nasal route using thiolated microspheres. Drug Del. 20(5): 210-215. (IF= 6.402)
19. Jain A, Jain A, Gulbake A, Shilpi S, Hurkat P & Jain SK. (2013). Peptide and protein delivery using new drug delivery systems. Cri Rev Ther Drug Carrier Sys. 30(4): 293–329. (IF= 3.32)
20. Jain A, Gulbake A, Shilpi S, Jain A, Hurkat P & Jain SK. (2013). Dual drug delivery using "smart" liposomes for triggered Release of anticancer agents. J Nanoparticle Res. 15(7): 1-12. (IF= 2.18)
21. Jain A, Gulbake A, Jain A, Shilpi S, Hurkat P, Kashaw S & Jain SK. (2013). Development and validation of HPLC method for simultaneous estimation of Paclitaxel and Topotecan, J Chrom Sci. 52(7): 697-703. (IF= 1.169)
22. Kharya P, Jain A, Gulbake A, Shilpi S, Jain A, Hurkat P, Majumdar S & Jain SK. (2013). Phenylalanine coupled solid lipid nanoparticles for brain tumor targeting. J Nanoparticle Res. 15(11): 1-12. (IF= 2.18)
23. Dangi R, Hurkat P, Jain A, Shilpi S, Jain A, Gulbake A, Jain SK. (2014). Targeting liver cancer via ASGP receptor using 5-Fu loaded surface modified PLGA nanoparticles. J Microencap. 31 (5): 479-487. (IF= 1.793)
24. Shrivastava M., Jain A, Gulbake A, Hurkat P, Jain N, Vijayraghwan R., Jain S.K. (2014). Low Density Lipid Nanoparticles for Solid Tumor Targeting. Sci Pharm. 82: 873–888. (IF= 0.86)
25. Sahu A., Jain A., Gulbake A. (2014). Colon as Target for Drug Delivery. Current Drug Therapy. 9: 63-73.
26. Subudhi M.B., Jain A, Jain A, Hurkat P, Shilpi S, Gulbake A. and Jain SK. (2015). Eudragit S100 Coated Citrus Pectin Nanoparticles for Colon Targeting of 5-Fluorouracil. Materials. 8: 832-849. (IF= 2.651)
27. Bansal D, Gulbake A, Tiwari J, Jain SK. (2016). Development of liposomes entrapped in alginate beads for the treatment of colorectal cancer. Int J Biol Macromol. 82: 687-695. (IF= 3.909)
28. Gulbake A, Jain A, Jain A, Jain A and Jain SK. (2016) Insight to drug delivery aspects for colorectal cancer. World J Gastroenterology. 22(2): 582-599. (IF= 3.365)
29. Gulbake A, Gupta PN, Gausia C, Sharma P, Saxena A and Jain SK. (2016) Polymeric nanocomposite: development, characterization, ex vivo and in vivo evaluation for ulcerative colitis. Int J Poly Mat. & Poly Biomat. 65 (7): 337-350. (IF= 3.568)
30. Dhumale S B, Sharma S, Gulbake A. (2017) Ano-Genital Warts and HIV Status– A Clinical Study. Journal of Clinical and Diagnostic Research. 11(1): WC01-WC04. (Scopus)
31. Sahu A, Jain A, Gulbake A. (2017) The Role of Carbon Nanotubes in Nanobiomedicines. Int J Pharmacy and Pharma Sci. (Conf Proc.). 9(6), 235-51.
32. Bhatt A, Gurnany E, Modi A, Gulbake A, Jain A. (2017) Theranostic Potential of Targeted Nanoparticles for Brain Cancer. Mini Rev Med Chem. 17, 18, 1758-1777. (IF= 2.903)
33. Sahu Gulbake A, Jain A, Shilpi S, Kumar P, Gulbake A. (2019) Mannosylated Multiwalled Carbon Nanotubes Assisted Artesunate Delivery for Cerebral Malaria. Int J App Pharm. 11, Special Issue 2, 24-30.
34. Momin T, Harugale S, Sahu Gulbake A, Gulbake A. (2019) Recent trends in siRNA delivery for treatment of colorectal cancer. Int J App Pharm. 11, Special Issue 2, 31-36.
35. Patake V. D., Ghogare T. T., Gulbake A. D., Lokhande C. D. (2019) The electrochemical performance of electrodeposited chitosan bio-nanopolymer in non-aqueous electrolyte: a new anodic material for supercapacitor. SN Applied Sciences (Springer Nature), 1:1063.
36. Joshi M.G., Gulbake A, Kashte S.B., Borude P., Apte U., Holgersson S. S. (2019) Xenobiotic-Induced Fetal Hepatocyte Maturation. Applied In Vitro Toxicology, 5 (4), 180-86.
37. Chauhan A., Ranjan R., Avti P., Gulbake A. (2020) Tailoring the nanoparticles surface for efficient cancer therapeutics. Int J App Pharm, 12, Special Issue 4, 11-17
38. Momin T., Gulbake A. (2020) Development and characterization of doxorubicin and siRNA encapsulated chitosan nanoparticles. Int J App Pharm, 12, Special Issue 4, 53-56.
39. Kashte S., Gulbake A., El‑Amin III S.F., Gupta A. (2021) COVID‑19 vaccines: rapid development, implications, challenges and future prospects. Human Cells, 34, 1-23 DOI: 10.1007/s13577-021-00512-4. (IF=3.46)
40. Tiwari R, Sethiya N.K., Gulbake A.S., Mehra N.K., Murty U.S.N., Gulbake A. (2021) A review on albumin as a biomaterial for ocular drug delivery. Int J Bio Macr, 191, 591-599. (IF=6.95)